FREMONT, CA, June 21, 2022 via NewMediaWire – ABVC Biopharma, Inc. , a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and. | June 21, 2022
ABVC BioPharma (ABVC) Submitted Vitargus Phase II Study Plan to Australia HREC streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
10.05.2022 - FREMONT, CA, May 10, 2022 (GLOBE NEWSWIRE) - via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that .